Shares of Moleculin Biotech Inc. were trading at $7.75 Thursday morning, above the company's issue price of $6, in the stock's debut on the Nasdaq. The company sold 1.5 million shares to raise about $9.2 million. Moleculin had initially hoped to raise up to $12 million, according to an earlier S-1 filing. Bonwick Capital Partners and Network 1 Financial Securities underwrote the offering.
Continue Reading Below
Copyright © 2016 MarketWatch, Inc.